Loading viewer...
investor_presentation
Format: PDF investor_presentation
Provention Bio presentation on intercepting autoimmunity to prevent chronic diseases, focusing on the clinical development and regulatory pathway of teplizumab. Discusses the company's mission to identify autoimmune diseases early and prevent debilitating outcomes through innovative therapeutic approaches.
investor_presentation
38 Pages
Kutcho Copper Corp.
Iovance Biotherapeutics Investor Presentation — August 2024
investor_presentationinvestor_presentation
34 Pages
Iovance Biotherapeutics, Inc
a.s.r. Acquires Generali Nederland 2017 – Dutch Insurance Deal
investor_presentationinvestor_presentation
6 Pages
a.s.r. (Algemene Spaarbank voor Ouderdomsvoorziening)
First of Long Island Corporation (FLIC) KBW Investor Presentation 2024
investor_presentationinvestor_presentation
32 Pages
First of Long Island Corporation